Shorter blood thinner treatment after heart stent for high bleeding risk
Part of Heart & circulation clinical trials.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You have been diagnosed with a heart attack or unstable chest pain (called acute coronary syndrome).
- Your doctor thinks you have a high risk of bleeding and is willing to treat you with blood thinners.
- You are planned to receive a heart stent, and your blocked artery is in a suitable location (not the main artery or fully blocked).
- You are not pregnant, planning to become pregnant, or planning to have a child during the trial.
- You are not scheduled for surgery in the next 12 months, and you have no allergies to aspirin or blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.
This trial tests whether choosing a shorter blood thinner treatment based on your genes, or reducing the dose, is safe and works well for people with high bleeding risk after getting a stent for a heart attack or chest pain.
This Phase 4 study tests whether using a reduced blood-thinner (antithrombotic) strategy after a heart attack can lower bleeding without losing heart protection. It is mainly for people considered high risk for bleeding after getting a stent.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This study looks at whether taking just one blood-thinning medicine (instead of two) after a stent procedure helps prevent future heart problems while lowering the risk of bleeding. It's for people who recently had a heart attack or unstable chest pain and had a stent placed.
Hear when a new Acute Coronary Syndrome (ACS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.